SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ishita Drugs & Industries trades higher on receiving Environmental Clearance from SEIAA

13 Sep 2022 Evaluate

Ishita Drugs & Industries is currently trading at Rs. 65.95, up by 1.20 points or 1.85% from its previous closing of Rs. 64.75 on the BSE.

The scrip opened at Rs. 66.20 and has touched a high and low of Rs. 74.90 and Rs. 65.35 respectively. So far 1123 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 79.55 on 05-May-2022 and a 52 week low of Rs. 34.00 on 23-Nov-2021.

Last one week high and low of the scrip stood at Rs. 75.50 and Rs. 50.20 respectively. The current market cap of the company is Rs. 19.54 crore.

The promoters holding in the company stood at 49.32%, while Non-Institutions held 50.68%.

Ishita Drugs & Industries has received an Environmental Clearance from the State Level Environment Impact Assessment Authority (SEIAA), Gujarat, for manufacturing additional products under the category 'Synthetic Organic Chemicals (API and its intermediates)' at its manufacturing unit situated at Sanand Viramgam Highway, Vasna-Iyava, Taluka Sanand, District Ahmedabad, Gujarat.

Ishita Drugs & Industries is engaged in the manufacture of various active pharma ingredients (bulk actives and their salts), bulk drug intermediates, excipients and fine chemicals. It has a state-of-art manufacturing facility, in terms of chemical synthesis, quality control and environmental safety.

Ishita Drugs & Inds. Share Price

80.45 1.45 (1.84%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×